Related Experiment Video

Updated: Mar 30, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

5.2K

TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling

Sang-A Park1, Min-Jin Kim1, So-Yeon Park1

  • 1College of Pharmacy, Ewha Womans University, Seoul, South Korea.

Scientific Reports
|November 10, 2015
PubMed

Insights

A novel small molecule, EW-7197, inhibits transforming growth factor-β (TGF-β) signaling. This targeted therapy reduces hepatocellular carcinoma (HCC) progression and metastasis by blocking crosstalk between hepatic stellate cells and cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-β (TGF-β) signaling is crucial for hepatocellular carcinoma (HCC) progression and metastasis.
  • Hepatic stellate cells (HSCs) and HCC cells communicate via TGF-β-mediated crosstalk.
  • Tissue inhibitors of metalloproteinases-1 (TIMP-1) are key mediators in this crosstalk.

Purpose of the Study:

  • To evaluate the anti-cancer potential of EW-7197, a small-molecule inhibitor of TGF-β type I receptor kinase, for HCC treatment.
  • To elucidate the role of TIMP-1 in TGF-β-mediated crosstalk between HSCs and HCC cells.

Main Methods:

  • Utilized an SK-HEP1-Luc orthotopic-xenograft mouse model to assess EW-7197's efficacy in vivo.
  • Investigated the molecular mechanisms, including TIMP-1 secretion, FAK signaling, and epithelial-to-mesenchymal transition (EMT).
  • Analyzed the impact of EW-7197 on HCC cell proliferation, motility, and survival.

Main Results:

  • EW-7197 significantly inhibited HCC progression and intrahepatic metastasis in the mouse model.
  • EW-7197 attenuated TGF-β-stimulated TIMP-1 secretion by HSCs and its downstream effects on HCC cells.
  • EW-7197 disrupted TGF-β-mediated EMT and Akt signaling, reducing HCC cell motility and anchorage-independent growth.

Conclusions:

  • TIMP-1 mediates TGF-β-regulated crosstalk between HSCs and HCC cells through FAK signaling.
  • EW-7197 demonstrates potent in vivo anti-cancer activity against HCC.
  • EW-7197 represents a potential novel therapeutic agent for liver cancer treatment.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.8K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K